With this validation, the application is complete, and the EMA will now begin the review procedure. Tepotinib is a highly selective oral MET inhibitor that is administered once The post EMA validates application for Tepotinib for treatment of advanced NSCLC with METex14 skipping alterations appeared first on Pharmaceutical Business review. … [Read more...]

The first-in-human trial initiated last year in healthy adults studied single and multiple doses of NaQuinate. The primary objective was to assess the safety, tolerability and pharmacokinetics. ”We The post Haoma Medica completes first-in-human trial for NaQuinate appeared first on Pharmaceutical Business review. … [Read more...]

1n 2019, Astellas and FibroGen have also received Japanese approval for roxadustat for the treatment of anaemia in adult patients with CKD and on dialysis. FibroGen now secures The post Astellas, FibroGen get approval in Japan for Evrenzo to treat anaemia of CKD in adult patients not on dialysis appeared first on Pharmaceutical Business review. … [Read more...]

As per terms of the proposed deal, the EC can increase their purchase of Covid-19 vaccine from 80 million doses to a total of up to 160 million The post EC approves agreement for purchase of Covid-19 vaccine candidate from Moderna appeared first on Pharmaceutical Business review. … [Read more...]

The global Phase II clinical trial is a randomised, double-blind, placebo-controlled and parallel-group trial designed to evaluate the efficacy and safety of CT-P59 in combination with standard of The post Celltrion completes enrolment for global phase II clinical trial with Covid-19 treatment candidate appeared first on Pharmaceutical Business review. … [Read more...]